MinRex Resources completes first East Pilbara programs

|

Published 31-MAY-2018 14:00 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

MinRex Resources Limited (ASX:MRR) has today informed the market it has now completed the first detailed geological evaluation and sampling program on the five East Pilbara tenements for which it currently holds a 70% interest.

Earlier in the year, MRR provided two updates relating to its Marble Bar North and South projects, including the recovery of gold nuggets from the Marble Bar North project tenement (P45/3040) announced in January. The following month, it released assay results for ten rock samples collected from the Marble Bar South project tenement (P45/3039).

The program MRR just finished involved a more detailed data compilation and review of historic mining and mineral exploration within the East Pilbara project areas, which can now provide a basis of information to inform the upcoming round of field exploration work.

The company is following the plan it had previously released to the market, that would see it initially focus on the collection of a significant number of rock samples from the areas of old workings at Marble Bar, and also the workings at the Daltons project and the previously defined prospect areas at the Bamboo Creek project.

The field team for the work was mobilised to the East Pilbara in May, collecting a total of 190 samples from old workings, prospects and outcropping rock formations. These samples have now been submitted for multi-element analysis at a laboratory in Perth, with assay results expected in mid-June 2018.

MRR hopes that the imminent results will add to the promising gold assay results and gold nuggets it obtained from the Marble Bar Project (both South and North project areas) earlier in the year. Once the sampling results are in, the company can then make decisions regarding which projects and areas to target in future efforts.

Of course, as with all minerals exploration, success is not guaranteed — consider your own personal circumstances before investing, and seek professional financial advice.

Marble Bar North tenement P45/3040, old workings and previous gold nugget locations.Current listing of the East Pilbara Tenement holdings of MinRex Resources.


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X